Nasdaq (NASDAQ:NDAQ) Price Target Increased to $79.00 by Analysts at UBS Group
Nasdaq (NASDAQ:NDAQ – Free Report) had its price target lifted by UBS Group from $73.00 to $79.00 in a research note published on Tuesday, Benzinga reports. UBS Group currently has a neutral rating on the financial services provider’s stock. NDAQ has been the subject of several other reports. Royal Bank of Canada reiterated an outperform […]
More Stories
Paylocity (NASDAQ:PCTY) Price Target Increased to $174.00 by Analysts at Barclays
Paylocity (NASDAQ:PCTY – Free Report) had its price objective boosted by Barclays from $156.00 to $174.00 in a report released...
Mirum Pharmaceuticals (NASDAQ:MIRM) Given “Buy” Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) in a research report released...
Sabra Health Care REIT (NASDAQ:SBRA) Price Target Increased to $18.00 by Analysts at Scotiabank
Sabra Health Care REIT (NASDAQ:SBRA – Free Report) had its price objective raised by Scotiabank from $17.00 to $18.00 in...
TORM (NASDAQ:TRMD) Shares Down 0% – Here’s Why
TORM plc (NASDAQ:TRMD – Get Free Report)’s share price dropped 0% during trading on Thursday . The company traded as...
Walgreens Boots Alliance (NASDAQ:WBA) Given New $7.00 Price Target at Morgan Stanley
Walgreens Boots Alliance (NASDAQ:WBA – Free Report) had its price objective reduced by Morgan Stanley from $9.00 to $7.00 in...
Cwm LLC Has $7.51 Million Position in CME Group Inc. (NASDAQ:CME)
Cwm LLC increased its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 50.7% during the 3rd...